Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 27, 2026
TickeronGET DAILY SIGNALS
Why Is Ryan Specialty Holdings (RYAN) Stock Down -5.49% Today?

Why Is Ryan Specialty Holdings (RYAN) Stock Down -5.49% Today?

Key Takeaways

  • RYAN shares fell 5.49% to about $42.03, down from the prior session's close of $44.47.
  • The decline reflects a mix of pre-earnings de-risking and persistent pressure from a softening commercial insurance pricing cycle.
  • Recent analyst price-target cuts — including reductions from Wells Fargo and Piper Sandler — continue to weigh on sentiment.
  • Ongoing insider selling and a competitive contract loss in Florida have added to the bearish backdrop.
  • Broader insurance-brokerage peers have faced similar headwinds as property and casualty rate momentum cools.
  • Traders are now focused on the company's third-quarter results, scheduled for release after the close on Thursday, October 29.
  • For deeper research, explore Price Targets, Earnings, and Forecast pages for this ticker.
  • Discover data-driven trading ideas in the Trending AI Robots section.

Opening Summary

Ryan Specialty Holdings, Inc. (RYAN) is a leading international specialty insurance firm that connects brokers, agents, and carriers through wholesale brokerage, binding authority, and underwriting management services. In Tuesday's trading session, shares of RYAN fell 5.49%, or $2.44, to roughly $42.03, compared with a prior-session close of $44.47. The decline extends a recent stretch of choppy trading as investors reposition ahead of the company's upcoming earnings report while contending with a cooling commercial property and casualty pricing environment.

Pre-Earnings Positioning Ahead of Third-Quarter Results

A key near-term catalyst is the company's third-quarter 2026 earnings release, scheduled for after the market close on Thursday, October 29. With results only days away, some investors are trimming exposure in favor of reducing risk ahead of what could be a volatile post-earnings reaction. Although the company has beaten bottom-line estimates in recent quarters, expectations point to a deceleration in overall revenue growth, leaving the stock vulnerable to profit-taking and de-risking as the report approaches.

Softening Commercial Insurance Pricing Cycle

The broader insurance-brokerage sector has been pressured by a weakening commercial insurance pricing cycle. Global commercial rates — particularly in property lines — have been sliding, and intensifying competition has raised concerns about margin compression and slower fee-income growth. As a specialty distributor that earns the bulk of its revenue from commissions and fees, RYAN is sensitive to these pricing dynamics, and the market reaction today reflects continued unease about the trajectory of the underwriting environment into 2026 and beyond.

Analyst Price-Target Cuts and Insider Selling

Sentiment has also been dented by a series of recent analyst moves. Wells Fargo lowered its price target to $41 while maintaining an Equal-Weight rating, and Piper Sandler reduced its target to $40 with a Neutral rating — both below recent trading levels. At the same time, continued insider selling has drawn investor attention, with regulatory filings showing corporate officers offloading shares over the past several months and few corresponding insider purchases. This combination of cautious sell-side views and insider disposals has reinforced the negative near-term tone.

Competitive Setback Adds to Pressure

Adding to the headwinds, a subsidiary of Ryan Specialty reportedly lost a contract bid related to Florida's Citizens Property Insurance clearinghouse to a competitor, prompting a formal protest. While the direct financial impact may be limited, the loss underscores the competitive intensity the firm faces in key specialty lines and has contributed to the cautious posture among investors.

Market Context and Trading Activity

The decline in RYAN is consistent with broader weakness across insurance-brokerage and specialty-insurance names as investors reassess exposure to a sector navigating a softer rate environment. Trading has remained active in recent sessions, with turnover running above the stock's average daily volume, suggesting meaningful participation behind the move rather than a thin-market outlier. Technically, the shares have given back a portion of the gains accumulated over the past month, and the pullback brings the stock closer to levels cited in recent analyst price targets, where some market participants view valuation as more balanced.

What Comes Next for RYAN

All eyes now turn to the company's third-quarter earnings report on October 29. Investors will scrutinize organic revenue growth, adjusted EBITDA margins, and management's commentary on the commercial pricing environment and competitive dynamics. Beyond earnings, key watch items include any further analyst rating changes, insider transaction activity, and sector-wide pricing data that could signal whether the current rate softness is stabilizing or accelerating. Risks include continued margin pressure from rate declines, intensifying competition in casualty and binding facilities, and the possibility that forward guidance disappoints even if headline results land in line with expectations.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that are among the strongest performers under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, each varying by strategy, timeframe, performance metrics, and traded symbols. Because only the top-performing bots are featured, the section helps traders quickly identify strategies that are working right now. Explore the Trending AI Robots page to see which automated approaches are gaining traction in today's market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RYAN

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RYAN saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for RYAN moved out of overbought territory on November 13, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 61 similar instances where the indicator exited the overbought zone. In 45 of the 61 cases the stock moved lower. This puts the odds of a downward move at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RYAN moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 22 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.

The Momentum Indicator moved below the 0 level on November 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RYAN as a result. In 56 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.

The Moving Average Convergence Divergence Histogram (MACD) for RYAN turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 30 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

RYAN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

RYAN moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RYAN crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +3.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYAN advanced for three days, in 200 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 143 of 249 cases where RYAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. RYAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYAN's P/B Ratio (11.438) is slightly higher than the industry average of (2.794). RYAN has a moderately high P/E Ratio (61.192) as compared to the industry average of (19.877). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.011) settles around the average of (0.042) among similar stocks. P/S Ratio (1.707) is also within normal values, averaging (3.106).

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 16B. The market cap for tickers in the group ranges from 3.03K to 97.74B. MRSH holds the highest valuation in this group at 97.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -9%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 17%. CRVL experienced the highest price growth at 3%, while ZBAO experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was -73%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 51
SMR Rating: 70
Profit Risk Rating: 84
Seasonality Score: 8 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Industry
N/A
Address
155 North Wacker Drive
Phone
+1 312 784-6001
Employees
6110
Web
https://www.ryanspecialty.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.